Citius Pharmaceuticals is trading 5.09% down now at $0.60, amid modestly lower broader markets, cautious Federal Reserve messaging, and weaker risk appetite.
- No new company-specific announcement was identified for August 28, 2026.
- The latest major company disclosure was fiscal third-quarter results and a business update released August 14, later updated August 26.
- The move does not meet the provided threshold for a clear company-specific catalyst; confidence is low because current-session coverage is limited.